Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study (Q40662197)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 1996
edit
Language Label Description Also known as
English
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study
scientific article published on November 1996

    Statements

    Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study (English)
    Tubergen DG
    Stewart CF
    Pratt CB
    Zamboni WC
    Winick N
    Santana VM
    Dryer ZA
    Kurtzberg J
    Bell B
    Grier H
    Vietti TJ
    1 November 1996
    352-361

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit